Psoriasis in People With Skin of Color: An Evidence‐Based Update
International Journal of Dermatology · 2025-04 · 64 (4) · 667-677
DOI: 10.1111/ijd.17651 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, online erschienen am 31.01.2025. Verfasst von Maria-Angeliki Gkini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Royal London Hospital,Barts Health NHS Trust, London, UK. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Variations in epidemiology, pathophysiology, genetics, clinical presentation, management, quality of life (QoL) impact, and access to care and research exist globally across the spectrum of individuals with psoriasis. This article aims to provide an evidence‐based update on the characteristics of psoriasis in individuals with skin of color (SOC), a population in which psoriasis data have historically been limited. A literature search was conducted from January 2018 until August 2023 in Pubmed/MEDLINE/Cochrane Library and identified studies with I‐III level of evidence using Oxford Centre for Evidence‐Based Medicine recommendations. Multiple factors (including biological and non‐biological) contribute to differences in clinical features and therapeutic nuances in patient populations with SOC. The prevalence of plaque psoriasis is lower in people with SOC but tends to be more severe. People with SOC are less likely to receive biologic treatment. Although the QoL impact of psoriasis is worse in populations with SOC than in White populations, more research is needed to elucidate variations in presentation and impact across diverse populations. An important limitation of this study is that ethnicity, race, and SOC have not been defined universally or used consistently in the literature. Available evidence provides limited information on populations with SOC outside North America, which limits generalizability across global populations. Furthering our understanding of psoriasis in individuals with SOC is crucial to improving patient care outcomes for diverse patient populations worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Royal London Hospital,Barts Health NHS Trust, London, UK.
- Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.
- Department of Dermatology, CES University, Medellin, Colombia.
- Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
- Hospital Militaire Tunis, Tunis, Tunisia.
ORCID-Profile: Mio Nakamura, Nejib Doss
Zitieren
APA
Gkini, M. A., Nakamura, M., Alexis, A. F., Londoño-Garcia, A., van de Kerkhof, P. C. M., Doss, N., Griffiths, C. E. M., Kaufman, B., Kleyn, C. E., Lebwohl, M., Redfern, J. S., Takeshita, J., Rajagopalan, M., & El Sayed, M. H. (2025). Psoriasis in People With Skin of Color: An Evidence‐Based Update. International Journal of Dermatology, 64(4), 667-677. https://doi.org/10.1111/ijd.17651
Vancouver
Gkini MA, Nakamura M, Alexis AF, Londoño-Garcia A, van de Kerkhof PCM, Doss N, et al. Psoriasis in People With Skin of Color: An Evidence‐Based Update. International Journal of Dermatology. 2025;64(4):667-677. doi:10.1111/ijd.17651
BibTeX
@article{Gkini2025,
author = {Gkini, Maria-Angeliki and Nakamura, Mio and Alexis, Andrew F and Londoño-Garcia, Angela and van de Kerkhof, Peter C M and Doss, Nejib and Griffiths, Christopher E M and Kaufman, Bridget and Kleyn, Christine E and Lebwohl, Mark and Redfern, Jan S and Takeshita, Junko and Rajagopalan, Murlidhar and El Sayed, Mahira H},
title = {Psoriasis in People With Skin of Color: An Evidence‐Based Update},
journal = {International Journal of Dermatology},
year = {2025},
volume = {64},
number = {4},
pages = {667--677},
doi = {10.1111/ijd.17651}
}
EUVIMED